PAEP and breast carcinoma: Based on the above, it can be speculated that the expression level or predictive effect of glycodelin for breast cancer may vary with eligible subjects, sample size, relevant experimental methods and operating conditions, and whether glycodelin is involved in the progression of different subtypes of breast cancer deserves further validation.